Protecting Health Care and Lowering Costs Act of 2025

The 'Protecting Health Care and Lowering Costs Act of 2025' (HR4849) was introduced in the House on August 1, 2025, and subsequently referred to the Committee on Ways and Means and the Committee on Energy and Commerce. This bill is in the early stages of the legislative process. It seeks to make permanent the expanded eligibility for and increased amount of the premium tax credit, which currently has a maximum income limit that is temporarily eliminated until 2025. The bill also proposes to repeal certain health-related tax provisions from the One Big Beautiful Bill Act (OBBBA). This legislation does not explicitly authorize a specific dollar amount of funding; instead, it modifies the tax code to expand eligibility for premium tax credits. This expansion would effectively increase the pool of individuals eligible for subsidies to purchase health insurance through exchanges. The mechanism is a tax credit, meaning the government would subsidize a larger portion of health insurance premiums for more individuals, thereby increasing demand for health insurance plans. This represents a structural increase in the potential customer base for health insurance providers. Structural winners from this bill would be health insurance providers, as an expanded premium tax credit directly translates to a larger insured population and potentially more stable revenue streams. Companies like UnitedHealth Group ($UNH), Humana Inc. ($HUM), and Molina Healthcare, Inc. ($MOH) are positioned to benefit from increased enrollment. CVS Health Corporation ($CVS), which operates Aetna, a major health insurance provider, would also benefit. The bill's focus on expanding access to health insurance directly supports the business models of these companies. Recent market data shows positive momentum for these health insurance stocks. Over the past 7 days, UnitedHealth Group ($UNH) has increased by +7.48% to $281.36, Humana Inc. ($HUM) by +10.03% to $182.65, and Molina Healthcare, Inc. ($MOH) by +9.04% to $143.36. CVS Health Corporation ($CVS) also saw a +4.48% increase to $73.28 in the same period. This recent upward trend suggests market participants may be anticipating favorable legislative developments or reacting to broader positive sector trends. The bill's early stage means it has a long legislative path ahead, requiring committee approval, floor votes in both chambers, and presidential assent.